Related Experiment Video
Updated: Jul 9, 2025
Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
Perioperative hemostatic management of patients with type A aortic dissection
Gabor Erdoes1, Aamer Ahmed2, Stephan D Kurz3
1Department of Anesthesiology and Pain Medicine, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland.
Insights
Coagulopathy in thoracic aortic repair requires careful management. Early diagnosis and tailored blood product therapy improve patient outcomes in complex cardiac surgery.
Area of Science:
- Cardiovascular Surgery
- Hematology
- Anesthesiology
Background:
- Coagulopathy is a frequent complication in patients undergoing thoracic aortic repair for Stanford type A aortic dissection.
- Inappropriate blood product administration can negatively impact surgical outcomes.
Purpose of the Study:
- To highlight the importance of understanding coagulopathy in complex cardiac surgery.
- To outline strategies for effective hemostatic management in thoracic aortic repair.
Main Methods:
- Collecting detailed medical history, including antithrombotic and anticoagulant drug use.
- Employing viscoelastic testing for sophisticated coagulopathy diagnosis.
- Adapting coagulation therapy using labile and stable blood products.
Main Results:
- Comprehensive patient assessment and tailored therapy are crucial.
- Intraoperative blood conservation and interdisciplinary communication enhance hemostasis.
Conclusions:
- Effective hemostatic management in thoracic aortic repair necessitates a multi-faceted approach.
- Integrating diagnostic testing, targeted therapy, and collaborative care optimizes patient safety and surgical success.
Abstract:
Coagulopathy is common in patients undergoing thoracic aortic repair for Stanford type A aortic dissection. Non-critical administration of blood products may adversely affect the outcome. It is therefore important to be familiar with the pathologic conditions that lead to coagulopathy in complex cardiac surgery. Adequate care of these patients includes the collection of the medical history regarding the use of antithrombotic and anticoagulant drugs, and a sophisticated diagnosis of the coagulopathy with viscoelastic testing and subsequently adapted coagulation therapy with labile and stable blood products. In addition to the above-mentioned measures, intraoperative blood conservation measures as well as good interdisciplinary coordination and communication contribute to a successful hemostatic management strategy.
